REPOST: NSF 21-100 DCL RENEWAL: BIO AND UKRI/BBSRC COLLABORATION AND BLOG ANNOUNCEMENT

Repost from our colleagues in the Division of Molecular and Cellular Biosciences (MCB).

The National Science Foundation’s Directorate for Biological Sciences (BIO) recently released Dear Colleague Letter (DCL) “UKRI/BBSRC-NSF/BIO Lead Agency Opportunity in Biological Informatics, Microbes and the Host Immune System, Quantum Biology and Synthetic Cell” (NSF 21-100). This DCL announces the continued collaboration between the UK Research and Innovation (UKRI) Biotechnology and Biological Sciences Research Council (BBSRC) and BIO on topics of strategic importance to both agencies. The topics for the coming fiscal year FY 2022 remain the same as those announced for FY 2021.

Under the lead agency agreement, researchers can submit a single collaborative proposal that will go through a streamlined review process either at NSF or at UKRI, on behalf of both NSF/BIO and UKRI/BBSRC.

Potential proposers should submit a letter of Intention to Submit (ITS) by September 22, 2021. If both agencies agree that the research topic fits the topical areas identified for FY 2022, researchers will be invited to submit a full proposal to the appropriate NSF or UKRI program.

Projects must address the priorities of both UKRI/BBSRC and participating NSF/BIO Divisions. Proposers must provide a clear rationale as to the need of the US-UK collaboration, including the unique expertise and collaboration that the team will bring to the project.

For full details on submission guidelines, program priorities, and contact information, see DCL NSF 21-100.